Bulletin of RSMU

ORIGINAL RESEARCH

Persistence of oncolytic Coxsackie virus A7 in subcutaneous human glioblastoma xenografts in mice in the context of experimental therapy

Sidorenko AS¹, Zheltukhin AO¹, Le TH¹, Soboleva AV^1,2, Lipatova AV¹, Golbin DA³, Chumakov PM^1,2

¹ Engelhardt Institute of Molecular Biology, Moscow

² Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow

³ Burdenko National Medical Research Center of Neurosurgery, Moscow

Correspondence should be addressed: Peter M. Chumakov
Vavilova 32, Moscow, 119991; moc.oohay@mpvokamuhc

About paper

Funding: the study was supported by the Ministry of Education and Science of the Russian Federation; project code RFMEFI60714X0014.

Received: 2018-07-13 Accepted: 2018-07-16 Published online: 2018-08-11

No data available...

Link to the next paper will be sent to the indicated e-mail's:

ORIGINAL RESEARCH Persistence of oncolytic Coxsackie virus A7 in subcutaneous human glioblastoma xenografts in mice in the context of experimental therapy

Sidorenko AS, Zheltukhin AO, Le TH, Soboleva AV, Lipatova AV, Golbin DA, Chumakov PM

Published in "Bulletin of RSMU" 3, 2018

I want to receive a copy of this message

Vancouver style

Sidorenko AS, Zheltukhin AO, Le TH, Soboleva AV, Lipatova AV, Golbin DA, et al. Persistence of oncolytic Coxsackie virus A7 in subcutaneous human glioblastoma xenografts in mice in the context of experimental therapy. Bulletin of RSMU. 2018; (3): 41–6. DOI: 10.24075/brsmu.2018.032

Harvard style

Sidorenko, A. S., Zheltukhin, A. O., Le, T. H., Soboleva, A. V., Lipatova, A. V., Golbin, D. A., et al. (2018), "Persistence of oncolytic Coxsackie virus A7 in subcutaneous human glioblastoma xenografts in mice in the context of experimental therapy", Bulletin of RSMU, no. 3, p. 41–46. DOI: 10.24075/brsmu.2018.032

Remember me

Forgot password?

I accept Editorial Policies of the journal

Archive

2018 / 03

ORIGINAL RESEARCH

Persistence of oncolytic Coxsackie virus A7 in subcutaneous human glioblastoma xenografts in mice in the context of experimental therapy